Stay updated on Dapagliflozin and Metformin in GDM Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin and Metformin in GDM Clinical Trial page.

Latest updates to the Dapagliflozin and Metformin in GDM Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedPage revision updated from v3.6.5 to v3.6.6, representing a minor maintenance update to the ClinicalTrials.gov page.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check40 days agoChange DetectedThe page revision tag changed from v3.6.4 to v3.6.5. This indicates an administrative update to the page, with no substantive changes to the study data or visible content.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing the previous v3.6.3, indicating a small update to the page’s version label.SummaryDifference0.1%

- Check76 days agoChange DetectedRevision updated from v3.6.2 to v3.6.3, indicating a minor underlying update to the page. The visible study details and layout remain unchanged.SummaryDifference0.1%

- Check83 days agoChange DetectedThe page shows Revision: v3.6.2, replacing the previous Revision: v3.6.0, indicating an updated revision history.SummaryDifference0.1%

- Check97 days agoChange DetectedThe page adds a recruitment-status note indicating no longer looking for participants and introduces new help sections (How to Read a Study Record, Common Questions, How to Join a Study). It also updates the Intervention/Treatment heading formatting to a different style.SummaryDifference0.4%

Stay in the know with updates to Dapagliflozin and Metformin in GDM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin and Metformin in GDM Clinical Trial page.